Sirtex Medical Europe GmbH


Correspondence: Deutsch, English
Operation Level: Regional, International, National

Address: Joseph Schumpeter Allee 33
53227 Bonn Germany
Phone: +49 228 184 07 30
Fax: +49 228 184 07 35
Web: https://www.sirtex.com


Sirtex Medical Limited is an Australian company with an approved cancer treatment supplied globally. Sirtex's main commercialised product is a targeted radioactive treatment for liver cancer called SIR-Spheres® Y-90 resin microspheres.

Over 100,000 doses of SIR-Spheres Y-90 resin microspheres have been supplied to treat liver cancer patients at over 1,230 medical centres in over 40 countries.

This product has PMA approval from the U.S. Food & Drug Administration (FDA), the European Union (CE Mark) and Australia's Therapeutic Goods Administration (TGA).

Sirtex has manufacturing capabilities in the U.S., Singapore and Germany.

JOURNEES FRANCAISES DE RADIOLOGIE
International radiology exhibition
13/10/2023 - 16/10/2023
Location Palais de Congres Paris - Porte Maillot
Paris
France
DCK - DEUTSCHER CHIRURGEN KONGRESS
International exhibition of general and visceral surgery
24/04/2024 - 26/04/2024
Location Congress Center Leipzig
Leipzig (changing)
Germany
EANM
International congress and exhibition of the European Association of Nuclear Medicine
19/10/2024 - 23/10/2024
Location CCH - Congress Center Hamburg
Hamburg (changing)
Germany